<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04230525</url>
  </required_header>
  <id_info>
    <org_study_id>Zuhal1</org_study_id>
    <nct_id>NCT04230525</nct_id>
  </id_info>
  <brief_title>Body Impedance Method in Patients Undergoing Urgent and Elective Cesarian Section</brief_title>
  <official_title>Noninvasive Evaluation of Hemodynamics by Using Body Impedance Method in Patients Undergoing Urgent and Elective Cesarian Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaziosmanpasa Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gaziosmanpasa Research and Education Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Independent form anesthetic methods, during C/S, considering both maternal and fetal&#xD;
      conditions, some crucial hemodynamic changes can appear and can be claimed non invasively&#xD;
      with the whole body bioimpedance. In this research, any kind of hemodynamic difference&#xD;
      between this method and urgent or elective C/S case will be detected and the clinic pursuit&#xD;
      can be developed creating an advantage in favor of both maternal and fetal conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Independent form anesthetic methods, during C/S, considering both maternal and fetal&#xD;
      conditions, some crucial hemodynamic changes can appear and can be claimed non invasively&#xD;
      with the whole body bioimpedance. In this research, any kind of hemodynamic difference&#xD;
      between this method and urgent or elective C/S case will be detected and the clinic pursuit&#xD;
      can be developed creating an advantage in favor of both maternal and fetal conditions. Under&#xD;
      general anesthesia, measuring the hemodynamic changes with the method of non-invasive&#xD;
      whole-body bioimpedance system during C/S.&#xD;
&#xD;
      Detection of in which phase of operations the potential changes densify and differences&#xD;
      between urgent and elective conditions non invasively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2020</start_date>
  <completion_date type="Anticipated">June 10, 2021</completion_date>
  <primary_completion_date type="Actual">June 5, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MAP</measure>
    <time_frame>1, 5, 15, and 30 minutes following the induction of the anesthesia</time_frame>
    <description>The difference in mean arterial pressure during the cesarean section between elective and emergency ceasreansection subjects</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">95</enrollment>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>Bioimpedence</arm_group_label>
    <description>Noninvasive hemodynamic changes will be observed by using whole-body impedance method urgent or elective cesarian section patients under general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>non invasive whole body bioimpedence system</intervention_name>
    <description>Noninvasive hemodynamic changes will be observed by using whole-body impedance method urgent or elective cesarian section patients under general anesthesia. The whole-body bioimpedance method will be used to monitör the hemodynamic changes non invasively. This method can evaluate such as cardiac output, cardiac index, stroke volüme, stroke index, stroke volüme variations, cardiac reserve, etc. Parameters with a completely noninvasive method by using only electrots. The device consists of a laptop, a software which calculates cardiac parameters and two electrodes. The measurement is done by the following process: one of these electrodes, which looks like ECG electrodes, is stuck to the wrist and the other one to the opposite ankle or each one to two wrists.</description>
    <arm_group_label>Bioimpedence</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Emergency or elective cesarean patients, which are between 18-45 years of age&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be scheduled for elective or emergency cesarean section&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of cardiac surgery, and advanced cardiac valvular disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Zuhal Cavus, MD</last_name>
    <phone>+902124041500</phone>
    <email>zuhalcavus74@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zuhal Cavus, Cavus</last_name>
    <phone>+902124041500</phone>
    <email>zuhalcavus74@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gaziosmanpaşa TREH</name>
      <address>
        <city>Istanbul</city>
        <state>Gaziosmanpaşa</state>
        <zip>34255</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>aygen türkmen, MD.prof.</last_name>
      <phone>+902129453000</phone>
      <email>aygenturkmen@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gaziosmanpasa Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Zuhal Çavuş</investigator_full_name>
    <investigator_title>Principal Investigator, M.D.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

